These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16497824)

  • 1. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading.
    Wöhrer S; Jaeger U; Kletter K; Becherer A; Hauswirth A; Turetschek K; Raderer M; Hoffmann M
    Ann Oncol; 2006 May; 17(5):780-4. PubMed ID: 16497824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
    Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K
    World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas.
    Karam M; Novak L; Cyriac J; Ali A; Nazeer T; Nugent F
    Cancer; 2006 Jul; 107(1):175-83. PubMed ID: 16721817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum.
    Hoffmann M; Chott A; Püspök A; Jäger U; Kletter K; Raderer M
    Ann Hematol; 2004 May; 83(5):276-8. PubMed ID: 15060746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.
    Bishu S; Quigley JM; Bishu SR; Olsasky SM; Stem RA; Shostrom VK; Holdeman KP; Paknikar S; Armitage JO; Hankins JH
    Leuk Lymphoma; 2007 Aug; 48(8):1548-55. PubMed ID: 17701586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma.
    Blum RH; Seymour JF; Wirth A; MacManus M; Hicks RJ
    Clin Lymphoma; 2003 Jun; 4(1):43-9. PubMed ID: 12837154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma.
    Adams HJ; Nievelstein RA; Kwee TC
    J Comput Assist Tomogr; 2017 Jan; 41(1):98-103. PubMed ID: 27560022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
    Kandeel AA; Hussein M; Zidan L; Younis J; Edesa W; Alsayed Y
    Nucl Med Commun; 2020 Mar; 41(3):269-279. PubMed ID: 31895758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on
    Makis W; Ciarallo A; Petrogiannis-Haliotis T; Rosenberg A; Probst S
    Clin Imaging; 2017; 43():88-92. PubMed ID: 28259031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging.
    Kumar R; Bhargava P; Zhuang H; Yu JQ; Schuster SJ; Alavi A
    Clin Nucl Med; 2004 Nov; 29(11):685-8. PubMed ID: 15483478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET/CT predictive role in follicular lymphoma.
    Lopci E; Zanoni L; Chiti A; Fonti C; Santi I; Zinzani PL; Fanti S
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):864-71. PubMed ID: 22354449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.
    Wondergem MJ; Rizvi SN; Jauw Y; Hoekstra OS; Hoetjes N; van de Ven PM; Boellaard R; Chamuleau ME; Cillessen SA; Regelink JC; Zweegman S; Zijlstra JM
    J Nucl Med; 2015 Feb; 56(2):216-21. PubMed ID: 25593118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
    Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database.
    Abou-Nassar KE; Vanderplas A; Friedberg JW; Abel GA; Niland J; Rodriguez MA; Czuczman MS; Millenson M; Crosby A; Gordon LI; Zelenetz AD; Kaminski M; Lacasce AS
    Leuk Lymphoma; 2013 Oct; 54(10):2155-62. PubMed ID: 23343180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure.
    Ng AP; Wirth A; Seymour JF; Lee M; Hogg A; Januszewicz H; Wolf M; Prince HM; Macmanus M; Hicks RJ
    Leuk Lymphoma; 2007 Mar; 48(3):596-600. PubMed ID: 17454604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type.
    Hoffmann M; Kletter K; Diemling M; Becherer A; Pfeffel F; Petkov V; Chott A; Raderer M
    Ann Oncol; 1999 Oct; 10(10):1185-9. PubMed ID: 10586335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.